Related Experiment Videos

Methotrexate for chronic diseases in adults

The New England Journal of Medicine

|February 2, 1995

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.

Scandinavian journal of rheumatology·2020

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.

Annals of the rheumatic diseases·2016

Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance.

Annals of the rheumatic diseases·2015

The influence of polygenic risk scores on heritability of anti-CCP level in RA.

Genes and immunity·2014

Clinical trials to establish methotrexate as a therapy for rheumatoid arthritis.

Clinical and experimental rheumatology·2010

American College of Rheumatology hybrid analysis of certolizumab pegol plus methotrexate in patients with active rheumatoid arthritis: data from a 52-week phase III trial.

Arthritis care & research·2010

See all related articles